CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Adherehealth and Levrx Technology Establish a Strategic Partnership to Improve Medication Optimization

Adherehealth and Levrx Technology...

Clinical Researchs Most Recent Developments

Clinical Researchs Most Recent...

Aceragen Receives Grant from Cystic Fibrosis Foundation to Advance Novel Therapy

Aceragen Receives Grant from Cystic...

Top Ways Netsuite Transforms Life Science Industry for Good

Top Ways Netsuite Transforms Life...

Rain Therapeutics and Roche to Jointly Conduct Immunotherapy Trial Solid Tumor Treatment

Rain Therapeutics and Roche to...

China biopharma sector focuses on innovation.

China biopharma sector focuses on...

4 Common Challenges in Clinical Trials - How Are You Addressing Them?

4 Common Challenges in Clinical...

What are the Key Pain Points in Managing Clinical Trials?

What are the Key Pain Points in...

Adherehealth and Levrx Technology Establish a Strategic Partnership to Improve Medication Optimization

Adherehealth and Levrx Technology...

Clinical Researchs Most Recent Developments

Clinical Researchs Most Recent...

Aceragen Receives Grant from Cystic Fibrosis Foundation to Advance Novel Therapy

Aceragen Receives Grant from Cystic...

Top Ways Netsuite Transforms Life Science Industry for Good

Top Ways Netsuite Transforms Life...

Rain Therapeutics and Roche to Jointly Conduct Immunotherapy Trial Solid Tumor Treatment

Rain Therapeutics and Roche to...

China biopharma sector focuses on innovation.

China biopharma sector focuses on...

4 Common Challenges in Clinical Trials - How Are You Addressing Them?

4 Common Challenges in Clinical...

What are the Key Pain Points in Managing Clinical Trials?

What are the Key Pain Points in...

Giuliano to Lead Finance-Related Leadership Functions as New CFO at Aeterna

Life Sciences Review Life Sciences Review | Friday, January 21, 2022
Tweet

Mr. La Fratta will take over the finance-related leadership roles as the new Senior Vice President and Chief Financial Officer of Aeterna Zentaris.


Fremont, CA: Dr. Klaus Paulini, Chief Executive Officer of Aeterna, comments, "We are very pleased to welcome Mr. La Fratta as our full-time Chief Financial Officer." Aeterna Zentaris Inc. has appointed Giuliano La Fratta as Senior Vice President, Chief Financial Officer. Aeterna Zentaris Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products. Mr. La Fratta will take over the finance-related leadership roles on January 24th, 2022, succeeding Ms. Leslie Auld, the Company's current Senior Vice President and Chief Financial Officer, who will focus on her financial consulting practice.


Mr. La Fratta is a senior financial executive with more than 20 years of expertise in the pharmaceutical, biopharmaceutical, and financial services industries. He has worked in both the public and private sectors, gaining valuable experience in leading and directing a wide range of financial activities, including mergers and acquisitions, corporate development, auditing, accounting, and administrative responsibilities. 


Mr. La Fratta was the Vice President of Finance at CellCarta (previously Caprion Biosciences), a private equity-owned specialty Clinical Research and Development Organization laboratory with global operations located in Montreal, Canada, prior to joining Aeterna Zentaris. 


Mr. La Fratta worked at IMS Canada Health (now Iqvia) and Cato Research before joining CellCarta. He began his career as a Senior Auditor at Deloitte Touche, working for both Canadian and American corporations in a variety of industries, including the pharmaceutical industry. Mr. La Fratta graduated from Concordia University with a bachelor's degree in accounting and is a CPA, CA.


“Aeterna has had a transformational year as a company. The team has done a great job to strengthen the financial position of the Company and to diversify Aeterna's development pipeline. Looking ahead, there are significant opportunities and key markets that I believe Aeterna is poised to address. I look forward to working with the team to capitalize on the opportunities ahead, with the goal of building value in the near and long term,” comments Mr. La Fratta.


Weekly Brief

loading
Top 10 Clinical Trial Services Companies - 2022
Top 10 Emerging Clinical Trial Management Companies - 2022
Top 10 Clinical Trial Management System Companies - 2022
Top 10 Clinical Trial Services Companies - 2022
Top 10 Emerging Clinical Trial Management Companies - 2022
Top 10 Clinical Trial Management System Companies - 2022
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis
Data Science In R&D: It Is About Culture

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore, at Lonza
Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Chris Dobbs, CEng., MIET, Head of Technical Engineering, PCI Pharma Services
Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Encouraging Innovation in Healthcare in a COVID - 19 World

Duncan Turner, General Partner, SOSV, Managing Director, HAX
Encouraging Innovation in Healthcare in a COVID - 19 World
How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

Gil Carrasquinho, VP Head of Cell Therapy, Santen
Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Craig Herron, Managing Director, iSelect Fund

Addressing the Expanded Role of Patient Engagement in Clinical Research

Denis Curtin, PhD, Principal, eCOA & Patient Engagement, Signant Health
Addressing the Expanded Role of Patient Engagement in Clinical Research

The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery

Jason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZeneca
The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/giuliano-to-lead-financerelated-leadership-functions-as-new-cfo-at-aeterna--nwid-698.html